A REVIEW OF ERASTIN MOLECULAR WEIGHT

Thus, it is not challenging to conclude that erastin therapy ends in ROS output followed by p53 activation which subsequently activates the p53 downstream pathway. Far more importantly, this method types a feed-back loop: erastin triggers an increase in ROS, which then brings about the activation of p53, which subsequently, results in elevated ROS.